IBDEI3B7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,877,0)
 ;;=HEADACHE^31^88
 ;;^UTILITY(U,$J,358.4,878,0)
 ;;=HEART VALVE DISEASE^32^88
 ;;^UTILITY(U,$J,358.4,879,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^88
 ;;^UTILITY(U,$J,358.4,880,0)
 ;;=HISTORY OF ILLNESS^34^88
 ;;^UTILITY(U,$J,358.4,881,0)
 ;;=INFECTIOUS DISEASE^35^88
 ;;^UTILITY(U,$J,358.4,882,0)
 ;;=LIVER DISEASE^36^88
 ;;^UTILITY(U,$J,358.4,883,0)
 ;;=MENTAL HEALTH^38^88
 ;;^UTILITY(U,$J,358.4,884,0)
 ;;=MOVEMENT DISORDERS^39^88
 ;;^UTILITY(U,$J,358.4,885,0)
 ;;=MUSCULOSKELETAL^40^88
 ;;^UTILITY(U,$J,358.4,886,0)
 ;;=NEUROLOGY^41^88
 ;;^UTILITY(U,$J,358.4,887,0)
 ;;=PAIN^42^88
 ;;^UTILITY(U,$J,358.4,888,0)
 ;;=PREVENTIVE HEALTH^43^88
 ;;^UTILITY(U,$J,358.4,889,0)
 ;;=PULMONARY^44^88
 ;;^UTILITY(U,$J,358.4,890,0)
 ;;=SEXUAL TRAUMA^45^88
 ;;^UTILITY(U,$J,358.4,891,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^88
 ;;^UTILITY(U,$J,358.4,892,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^88
 ;;^UTILITY(U,$J,358.4,893,0)
 ;;=SUBSTANCE DISORDERS^48^88
 ;;^UTILITY(U,$J,358.4,894,0)
 ;;=VARICOSE VEINS^50^88
 ;;^UTILITY(U,$J,358.4,895,0)
 ;;=WOMEN'S HEALTH^51^88
 ;;^UTILITY(U,$J,358.4,896,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^88
 ;;^UTILITY(U,$J,358.4,897,0)
 ;;=COMA^20^88
 ;;^UTILITY(U,$J,358.4,898,0)
 ;;=CAUSES OF INJURY^19^88
 ;;^UTILITY(U,$J,358.4,899,0)
 ;;=DEMENTIA^21^88
 ;;^UTILITY(U,$J,358.4,900,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^88
 ;;^UTILITY(U,$J,358.4,901,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^88
 ;;^UTILITY(U,$J,358.4,902,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^88
 ;;^UTILITY(U,$J,358.4,903,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^88
 ;;^UTILITY(U,$J,358.4,904,0)
 ;;=ACSC ANGINA^4^88
 ;;^UTILITY(U,$J,358.4,905,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^88
 ;;^UTILITY(U,$J,358.4,906,0)
 ;;=ACSC CHF^6^88
 ;;^UTILITY(U,$J,358.4,907,0)
 ;;=ACSC DEHYDRATION^7^88
 ;;^UTILITY(U,$J,358.4,908,0)
 ;;=ACSC DIABETES TYPE 1^8^88
 ;;^UTILITY(U,$J,358.4,909,0)
 ;;=ACSC DIABETES TYPE 2^9^88
 ;;^UTILITY(U,$J,358.4,910,0)
 ;;=ACSC HYPERTENSION^10^88
 ;;^UTILITY(U,$J,358.4,911,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^88
 ;;^UTILITY(U,$J,358.4,912,0)
 ;;=ACSC PNEUMONIA^12^88
 ;;^UTILITY(U,$J,358.4,913,0)
 ;;=ACSC UTI^13^88
 ;;^UTILITY(U,$J,358.4,914,0)
 ;;=ACSC VIRAL ENTERITIS^14^88
 ;;^UTILITY(U,$J,358.4,915,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^88
 ;;^UTILITY(U,$J,358.4,916,0)
 ;;=TEAM CONFERENCE^10^89
 ;;^UTILITY(U,$J,358.4,917,0)
 ;;=PROCEDURE CODE^8^89
 ;;^UTILITY(U,$J,358.4,918,0)
 ;;=EDUCATION/TRAINING^2^89
 ;;^UTILITY(U,$J,358.4,919,0)
 ;;=IMMUNIZATIONS^4^89
 ;;^UTILITY(U,$J,358.4,920,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^5^89
 ;;^UTILITY(U,$J,358.4,921,0)
 ;;=SKIN TEST^9^89
 ;;^UTILITY(U,$J,358.4,922,0)
 ;;=PREVENTIVE MED-EST PT^6^89
 ;;^UTILITY(U,$J,358.4,923,0)
 ;;=PREVENTIVE MED-NEW PT^7^89
 ;;^UTILITY(U,$J,358.4,924,0)
 ;;=ADVANCED CARE PLANNING^1^89
 ;;^UTILITY(U,$J,358.4,925,0)
 ;;=IMMUNIZATION ADMINISTRATION^3^89
 ;;^UTILITY(U,$J,358.4,926,0)
 ;;=PSYCHOTHERAPY (INPT/OPT/HOME)^6^90
 ;;^UTILITY(U,$J,358.4,927,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^7^90
 ;;^UTILITY(U,$J,358.4,928,0)
 ;;=OTHER CODES^4^90
 ;;^UTILITY(U,$J,358.4,929,0)
 ;;=HLTH/BEHAV ASSESS/INTERVENTION^1^90
 ;;^UTILITY(U,$J,358.4,930,0)
 ;;=TEAM CONFERENCE^9^90
 ;;^UTILITY(U,$J,358.4,931,0)
 ;;=INTERACTIVE COMPLEXITY ADD-ON^2^90
 ;;^UTILITY(U,$J,358.4,932,0)
 ;;=SUBSTANCE USE & MISC SERVICES^8^90
 ;;^UTILITY(U,$J,358.4,933,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^5^90
